1. Persistent low prevalence of hepatitis B vaccination among people with HIV: Time for a change?
- Author
-
Garcia A, Vigil KJ, Taylor B, Kshirsagar O, Thamer M, and Jain MK
- Subjects
- Humans, Hepatitis B Vaccines, Prevalence, Retrospective Studies, Hepatitis B virus, Vaccination, Hepatitis B epidemiology, Hepatitis B prevention & control, Liver Neoplasms complications, HIV Infections complications, HIV Infections epidemiology
- Abstract
Hepatitis B virus (HBV) infection is one of the leading causes of hepatocellular carcinoma and mortality among people living with HIV (PLWH). HBV vaccination provides protection from infection; however, vaccination rates are low. We conducted a retrospective analysis at three HIV centres in Texas to determine the proportion of PLWH who received the recommended 3 doses of hepatitis B vaccine within 1 year. Factors associated with vaccination completion were explored. In our sample of three sites in a state with high HIV transmission and high rates of liver disease from 2011 to 2021, showed low rates of hepatitis B vaccination. Among eligible PLWH, only 9% completed the 3-dose hepatitis B vaccine series in 1 year. There is an urgent need to improve HBV vaccination to reach 2030 target for hepatitis B elimination., (© 2023 The Authors. Journal of Viral Hepatitis published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF